Similar Posts
Survey Reveals Orphan Drugs Companies are Hindered by Internal Limitations
Orphan drugs encounter challenges that extend from their initial discovery to eventual launch, primarily due to the restricted patient numbers and niche…
The Role of Roller Compaction in Dose Design
Introduction: Roller compaction is a popular dry granulation process with some significant advantages over wet granulation processes. It offers better overall stability…
How To Create An Bioavailability Enhanced Formulation
Utilizing strategies that conserve active pharmaceutical ingredient (API) quantities and pinpointing scalable formulation technologies suitable for boosting drug solubility and augmenting oral…
PBPK Modelling: Optimizing Controlled Release Dosage Form Development
Creating controlled release drugs, which release medicine at a specific rate or location in the digestive system, can be difficult. Physiologically-based pharmacokinetic…
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Renejix’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Customer Requirements for Oral Dose Development
Pharmaceutical developers aim for cost-effective oral medications that work well. This can be challenging, requiring an understanding of client, patient, and provider…